Table 4.
Category | Accepted (%) | Denied (%) |
---|---|---|
Risk to Patient | ||
Allergy | 2 (100) | 0 (0) |
Medication error | 2 (100) | 0 (0) |
Monitoring for toxicity | 7 (70.0) | 3 (30.0) |
Actual ADE | 8 (50.0) | 8 (50.0) |
Potential ADE | 61 (44.9) | 75 (55.1) |
Medication Indication | ||
No/Unclear indication | 6 (60.0) | 4 (40.0) |
Undertreated condition | 24 (42.9) | 32 (57.1) |
Untreated condition | 43 (41.7) | 60 (58.3) |
Alternative therapy | 4 (16.0) | 21 (84.0) |
Efficacy | ||
Adherence or administration issue | 7 (70.0) | 3 (30.0) |
Therapeutic monitoring for effectiveness | 13 (31.0) | 29 (69.0) |
Minimal effectiveness | 2 (28.6) | 5 (71.4) |
Pharmaceutical | ||
Inappropriate route | 1 (100) | 0 (0) |
Therapeutic duplication | 8 (80.0) | 2 (20.0) |
Inappropriate dose | 24 (54.5) | 20 (45.5) |
Inappropriate schedule | 1 (33.3) | 2 (66.7) |